TapewireFind a company

person · Reporting owner

Boor Kathryn Jean

Disclosed activity across 3 companies

Tapewire entity
41123
SEC CIK
0001761826

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
INTERNATIONAL FLAVORS & FRAGRANCES INCIFF · Entity 3234DirectorMay 01, 2025May 05, 2025
Sarepta Therapeutics, Inc.SRPT · Entity 4426DirectorJune 04, 2026June 06, 2026
Seneca Foods CorpSENEA · Entity 4744DirectorDecember 07, 2018December 14, 2018

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

INTERNATIONAL FLAVORS & FRAGRANCES INC

Report date May 01, 2025 · Filed May 05, 2025

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2026-05-01Direct2,569 Reported balance After 2025-05-01 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2025-05-01 · Grant · Acquired 2,569 · Balance 2,569

F1: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis.

F2: Represent RSUs granted under the Non-Employee Director Compensation Program.

F3: The RSUs will vest on the one-year anniversary of the grant date.

Filing footnotes · ownership attribution and instrument terms

F1: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis.

F2: Represent RSUs granted under the Non-Employee Director Compensation Program.

F3: The RSUs will vest on the one-year anniversary of the grant date.

Sarepta Therapeutics, Inc.

Report date June 04, 2026 · Filed June 06, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect25,138 Reported balance After 2026-06-04 transaction · row 1
1 source row

Row 1 · 2026-06-04 · Grant · Acquired 16,875 · Balance 25,138

F1: The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs will vest on earlier of the one-year anniversary of the date of grant and the next annual meeting of stockholders which is at least 50 weeks after the immediately preceding year's annual meeting.

Filing footnotes · ownership attribution and instrument terms

F1: The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs will vest on earlier of the one-year anniversary of the date of grant and the next annual meeting of stockholders which is at least 50 weeks after the immediately preceding year's annual meeting.

Seneca Foods Corp

Report date December 07, 2018 · Filed December 14, 2018

This filing explicitly reported no securities owned.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
June 04, 2026 Filed Jun 6, 2026 00:11 UTC Sarepta Therapeutics, Inc. SRPT · Entity 4426 GrantCommon Stock 16,875 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-26-260263 · ownership.xml · nonDerivative · entry 1

Boor Kathryn Jean · CIK 0001761826 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,138

F1 · price: The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs will vest on earlier of the one-year anniversary of the date of grant and the next annual meeting of stockholders which is at least 50 weeks after the immediately preceding year's annual meeting.

Read SEC document
May 01, 2025 Filed May 5, 2025 21:57 UTC INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 GrantRestricted Stock Units · Derivative 2,569 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-004752 · doc4.xml · derivative · entry 1

Boor Kathryn Jean · CIK 0001761826 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,569

Underlying: Common Stock · 2,569 shares

Expires 2026-05-01

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis.

F2 · shares: Represent RSUs granted under the Non-Employee Director Compensation Program.

F3 · derivative.exercise_date: The RSUs will vest on the one-year anniversary of the grant date.

F3 · derivative.expiration_date: The RSUs will vest on the one-year anniversary of the grant date.

Read SEC document
March 10, 2025 Filed Mar 12, 2025 00:00 UTC Sarepta Therapeutics, Inc. SRPT · Entity 4426 GrantStock Options (right to buy) · Derivative 4,792 $0.00 Strike: $99.69 $0.00
Disclosure

SEC source: 0000950170-25-037532 · ownership.xml · derivative · entry 2

Boor Kathryn Jean · CIK 0001761826 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,792

Underlying: Common Stock · 4,792 shares

Expires 2035-03-10

Read SEC document
March 10, 2025 Filed Mar 12, 2025 00:00 UTC Sarepta Therapeutics, Inc. SRPT · Entity 4426 GrantCommon Stock 2,383 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-25-037532 · ownership.xml · nonDerivative · entry 1

Boor Kathryn Jean · CIK 0001761826 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,263

F1 · price: The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 10, 2026.

Read SEC document
December 05, 2024 Filed Dec 7, 2024 01:00 UTC Sarepta Therapeutics, Inc. SRPT · Entity 4426 SaleCommon Stock 1,636 $125.55 $205,399.80
Disclosure

SEC source: 0000950170-24-134285 · ownership.xml · nonDerivative · entry 1

Boor Kathryn Jean · CIK 0001761826 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,880

F1 · shares: Represents a sale of shares of common stock to generate cash for the payment of taxes due as a result of the vesting of certain restricted stock unit awards.

Read SEC document
May 01, 2024 Filed May 3, 2024 21:28 UTC INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 GrantRestricted Stock Units · Derivative 1,875 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-005618 · doc4.xml · derivative · entry 2

Boor Kathryn Jean · CIK 0001761826 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,875

Underlying: Common Stock · 1,875 shares

Expires 2025-05-01

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis.

F2 · shares: Represent RSUs granted under the Non-Employee Director Compensation Program.

Read SEC document
March 11, 2024 Filed Mar 12, 2024 00:00 UTC Sarepta Therapeutics, Inc. SRPT · Entity 4426 SaleCommon Stock 761 $122.93 $93,549.73
Disclosure

SEC source: 0000950170-24-029531 · ownership.xml · nonDerivative · entry 1

Boor Kathryn Jean · CIK 0001761826 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,516

F1 · shares: Represents a sale of shares of common stock to generate cash for the payment of taxes due as a result of the vesting of certain restricted stock unit awards.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 01:00 UTC Sarepta Therapeutics, Inc. SRPT · Entity 4426 GrantStock Option (right to buy) · Derivative 3,679 $0.00 Strike: $128.67 $0.00
Disclosure

SEC source: 0000950170-24-026616 · ownership.xml · derivative · entry 2

Boor Kathryn Jean · CIK 0001761826 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,679

Underlying: Common Stock · 3,679 shares

Expires 2034-03-01

Read SEC document
March 01, 2024 Filed Mar 6, 2024 01:00 UTC Sarepta Therapeutics, Inc. SRPT · Entity 4426 GrantCommon Stock 1,846 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-026616 · ownership.xml · nonDerivative · entry 1

Boor Kathryn Jean · CIK 0001761826 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,277

F1 · price: The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 1, 2025.

Read SEC document
May 04, 2023 Filed May 5, 2023 23:32 UTC INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 GrantStock Equivalent Unit · Derivative 1,245 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-005522 · doc4.xml · derivative · entry 3

Boor Kathryn Jean · CIK 0001761826 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,350.793

Underlying: Common Stock · 1,245 shares

Expires not disclosed

F3 · derivative.exercise_price: The Units convert to Common Stock on a one-for-one basis.

F2 · price: Upon the vesting of RSUs on May 4, 2023, the reporting person deferred the receipt of 1,245 shares of Common Stock and received instead 1,245 Stock Equivalent Units ("Units") pursuant to the Company's deferred compensation plan.

F4 · derivative.exercise_date: The Units are payable in Common Stock upon the earlier of the reporting person ceasing to serve as a member of the Company's Board of Directors or January 1 following retirement.

F4 · derivative.expiration_date: The Units are payable in Common Stock upon the earlier of the reporting person ceasing to serve as a member of the Company's Board of Directors or January 1 following retirement.

Read SEC document
May 04, 2023 Filed May 5, 2023 23:32 UTC INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 Disposition to issuerRestricted Stock Units · Derivative 1,245 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-005522 · doc4.xml · derivative · entry 2

Boor Kathryn Jean · CIK 0001761826 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,245 shares

Expires 2023-05-04

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis.

F2 · price: Upon the vesting of RSUs on May 4, 2023, the reporting person deferred the receipt of 1,245 shares of Common Stock and received instead 1,245 Stock Equivalent Units ("Units") pursuant to the Company's deferred compensation plan.

Read SEC document
March 06, 2023 Filed Mar 9, 2023 01:00 UTC Sarepta Therapeutics, Inc. SRPT · Entity 4426 GrantStock Option (right to buy) · Derivative 3,257 $0.00 Strike: $155.99 $0.00
Disclosure

SEC source: 0001209191-23-017399 · doc4.xml · derivative · entry 2

Boor Kathryn Jean · CIK 0001761826 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,257

Underlying: Common Stock · 3,257 shares

Expires 2033-03-06

Read SEC document
March 06, 2023 Filed Mar 9, 2023 01:00 UTC Sarepta Therapeutics, Inc. SRPT · Entity 4426 GrantCommon Stock 1,523 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-017399 · doc4.xml · nonDerivative · entry 1

Boor Kathryn Jean · CIK 0001761826 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,431

F1 · price: The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 6, 2024.

Read SEC document
June 02, 2022 Filed Jun 7, 2022 00:24 UTC Sarepta Therapeutics, Inc. SRPT · Entity 4426 GrantStock Option (right to buy) · Derivative 8,329 $0.00 Strike: $72.58 $0.00
Disclosure

SEC source: 0001209191-22-034740 · doc4.xml · derivative · entry 2

Boor Kathryn Jean · CIK 0001761826 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,329

Underlying: Common Stock · 8,329 shares

Expires 2032-06-02

F2 · derivative.exercise_date: The option vests in three equal annual installments beginning June 2, 2023.

Read SEC document
June 02, 2022 Filed Jun 7, 2022 00:24 UTC Sarepta Therapeutics, Inc. SRPT · Entity 4426 GrantCommon Stock 4,908 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-034740 · doc4.xml · nonDerivative · entry 1

Boor Kathryn Jean · CIK 0001761826 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,908

F1 · price: The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs vest in three equal annual installments beginning June 2, 2023.

Read SEC document
May 05, 2022 Filed May 6, 2022 21:55 UTC INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 GrantStock Equivalent Unit · Derivative 1,089 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-006651 · doc4.xml · derivative · entry 4

Boor Kathryn Jean · CIK 0001761826 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,089

Underlying: Common Stock · 1,089 shares

Expires not disclosed

F4 · derivative.exercise_price: The Units convert to Common Stock on a one-for-one basis.

F3 · price: Upon the vesting of RSUs on May 5, 2022, the reporting person deferred the receipt of 1,089 shares of Common Stock and received instead 1,089 Stock Equivalent Units ("Units") pursuant to the Company's deferred compensation plan.

F5 · derivative.exercise_date: The Units are payable in Common Stock upon the earlier of the reporting person ceasing to serve as a member of the Company's Board of Directors or January 1 following retirement.

F5 · derivative.expiration_date: The Units are payable in Common Stock upon the earlier of the reporting person ceasing to serve as a member of the Company's Board of Directors or January 1 following retirement.

Read SEC document
May 05, 2022 Filed May 6, 2022 21:55 UTC INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 Disposition to issuerRestricted Stock Units · Derivative 1,089 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-006651 · doc4.xml · derivative · entry 3

Boor Kathryn Jean · CIK 0001761826 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,089 shares

Expires 2022-05-05

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis.

F3 · price: Upon the vesting of RSUs on May 5, 2022, the reporting person deferred the receipt of 1,089 shares of Common Stock and received instead 1,089 Stock Equivalent Units ("Units") pursuant to the Company's deferred compensation plan.

Read SEC document
May 04, 2022 Filed May 6, 2022 21:55 UTC INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 GrantRestricted Stock Units · Derivative 1,245 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-006651 · doc4.xml · derivative · entry 2

Boor Kathryn Jean · CIK 0001761826 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,245

Underlying: Common Stock · 1,245 shares

Expires 2023-05-04

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis.

F2 · shares: Represent RSUs granted under the Non-Employee Director Compensation Program.

Read SEC document
May 06, 2021 Filed May 8, 2021 01:44 UTC INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 Exercise / conversionRestricted Stock Units · Derivative 255 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-007795 · doc4.xml · derivative · entry 3

Boor Kathryn Jean · CIK 0001761826 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 255 shares

Expires 2021-05-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis.

F1 · price: Upon the vesting of Restricted Stock Units ("RSUs") on May 6, 2021, the reporting person did not defer the receipt of 255 shares of Common Stock pursuant to IFF's deferred compensation plan.

Read SEC document
May 06, 2021 Filed May 8, 2021 01:44 UTC INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 Exercise / conversionCommon Stock 255 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-007795 · doc4.xml · nonDerivative · entry 1

Boor Kathryn Jean · CIK 0001761826 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 255

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Upon the vesting of Restricted Stock Units ("RSUs") on May 6, 2021, the reporting person did not defer the receipt of 255 shares of Common Stock pursuant to IFF's deferred compensation plan.

Read SEC document
May 05, 2021 Filed May 8, 2021 01:44 UTC INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 GrantRestricted Stock Units · Derivative 1,089 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-007795 · doc4.xml · derivative · entry 2

Boor Kathryn Jean · CIK 0001761826 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,089

Underlying: Common Stock · 1,089 shares

Expires 2022-05-05

F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis.

F3 · shares: Represent RSUs granted under the Non-Employee Director Compensation Program.

Read SEC document
March 01, 2021 Filed Mar 3, 2021 22:08 UTC INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 GrantRestricted Stock Units · Derivative 255 $0.00 $0.00
Disclosure

SEC source: 0001225208-21-004530 · doc4.xml · derivative · entry 1

Boor Kathryn Jean · CIK 0001761826 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 255

Underlying: Common Stock · 255 shares

Expires 2021-05-06

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis.

F2 · shares: Represent RSUs granted under the Non-Employee Director Compensation Program.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.